Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 10/20 | 0.35 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | FPR3 | P25089 | 1/20 | 0.34 |
| ▸ | FPR2 | P25090 | 1/20 | 0.34 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.33 |
| ▸ | CXCR3 | P49682 | 1/20 | 0.33 |
| ▸ | P2RX7 | Q99572 | 3/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | CASP2 | P42575 | 1/20 | 0.31 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Iodide SCHEMBL1677836 | 0.99 | EPHX2 (0.35) | EPHX2EPHX1ALDH1A1SMN1; SMN2FPR3 | |
| SCHEMBL1677543 | 0.89 | P2RX7 (0.39) | EPHX2EPHX1ALDH1A1SMN1; SMN2FPR3 | |
| SCHEMBL1678508 | 0.85 | P2RX7 (0.39) | EPHX2EPHX1ALDH1A1SMN1; SMN2FPR3 | |
| SCHEMBL1677528 | 0.85 | P2RX7 (0.39) | EPHX2EPHX1ALDH1A1SMN1; SMN2FPR3 | |
| SCHEMBL1678221 | 0.82 | P2RX7 (0.38) | EPHX2EPHX1ALDH1A1SMN1; SMN2HDAC11 | |
| Iodide SCHEMBL1677581 | 0.81 | EPHX2 (0.40) | EPHX2EPHX1ALDH1A1SMN1; SMN2P2RX7 | |
| SCHEMBL1678145 | 0.81 | P2RX7 (0.37) | EPHX2EPHX1ALDH1A1SMN1; SMN2HDAC11 | |
| SCHEMBL1678526 | 0.80 | NAMPT (0.42) | EPHX2EPHX1ALDH1A1SMN1; SMN2P2RX7 | |
| SCHEMBL1679354 | 0.80 | P2RX7 (0.42) | EPHX2EPHX1ALDH1A1SMN1; SMN2HDAC11 | |
| SCHEMBL1677680 | 0.78 | P2RX7 (0.40) | EPHX2EPHX1ALDH1A1SMN1; SMN2HDAC11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1743885-B1 | 1-[(adamantyl)alkyl]-3-[(pyridinyl)alkyl]urea compounds as TNF-.alpha inhibitors useful for autoimmune diseases | SANTEN PHARMACEUTICAL CO LTD (JP) | 2009-11-11 | — | — | EP | disclosed |
| EP-1743885-A2 | TNF-Alpha Produktion Hemmer zur Behandlung von Autoimmunerkrankungen | SANTEN PHARMACEUTICAL CO., LTD. (JP) | 2007-01-17 | — | — | EP | disclosed |